KR950702978A - 아미드 유도체(Amide derivatives) - Google Patents

아미드 유도체(Amide derivatives) Download PDF

Info

Publication number
KR950702978A
KR950702978A KR1019950700456A KR19950700456A KR950702978A KR 950702978 A KR950702978 A KR 950702978A KR 1019950700456 A KR1019950700456 A KR 1019950700456A KR 19950700456 A KR19950700456 A KR 19950700456A KR 950702978 A KR950702978 A KR 950702978A
Authority
KR
South Korea
Prior art keywords
compound
aryl
alkyl
hydrogen
formula
Prior art date
Application number
KR1019950700456A
Other languages
English (en)
Inventor
앤터니 클리프 이안
채프맨 화이트 앨런
Original Assignee
폴 에이. 리처
존 와이어스 앤드 브라더 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929216649A external-priority patent/GB9216649D0/en
Priority claimed from GB939307958A external-priority patent/GB9307958D0/en
Application filed by 폴 에이. 리처, 존 와이어스 앤드 브라더 리미티드 filed Critical 폴 에이. 리처
Publication of KR950702978A publication Critical patent/KR950702978A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

일반식(I)의 아미드 유도체 및 약제학적으로 허용되는 이의 염은 5-HT1A결합제이며 예를 들어 불안증 치료제로서 사용될 수 있다.
상기식에서, a 및 b는 각각 0,1,2 또는 3이고, 단 a와 b의 합은 0,1,2 또는 3이며,은 임의의 이중결합이고, A는 임의로 치환된 C1-2-알킬렌 쇄이고, R은 모노 또는 비사이클릭 아릴 또는 헤테로아릴 라디칼이고, R1은 수소 또는 저급 알킬이고, R2는 아릴, 아르알킬, 헤테로아릴 또는 헤테로아릴알킬이고 -CONR3R4는 특정의 아미드 그룹을 나타낸다.

Description

아미드 유도체(Amide derivatives)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 일반식(I)의 화합물 또는 약제학적으로 허용되는 이의 산 부가염.
    상기식에서, a 및 b는 각각 0,1,2 또는 3이고, 단 a와 b의 합은 0,1,2 또는 3이며,은 a가 1이상인 경우, 환에 존재할 수 있는 임의의 이중결합이고, A는 하나 이상의 저급 알킬 그룹에 의해 임의로 치환된 탄소수 1 또는 2의 알킬렌 쇄이고, R은 모노 또는 비사이클릭 아릴 또는 헤테로아릴 라디칼이고, R1은 수소 또는 저급 알킬이고, R2는 아릴, 아릴(저급)알킬, 헤테로아릴 또는 헤테로아릴(저급)알킬 라디칼이고, R3은 수소 또는 저급 알킬이고, R4는 수소, 탄소수 1 내지 10의 알킬 그룹, 탄소수 3 내지 12의 사이클로알킬, 사이클로알킬(저급)알킬, 아릴 또는 아릴(저급)알킬이거나, R3과 R4는, 이들이 결합되어 있는 질소원자와 함께 추가의 헤테로 원자를 함유할 수 있는 포화 헤테로사이클릭 환율을 나타낸다.
  2. 제1항에 있어서, R이 임의로 치환된 페닐 라디칼인 화합물.
  3. 제1항 또는 제2항에 있어서, A가 -CH2또는 -CH2-CH2-인 화합물.
  4. 제1항 내지 제3항 중의 어느 한 항에 있어서, R2가 치환되거나 치환되지 않은 페닐인 화합물.
  5. 제1항 내지 제4항 중의 어느 한 항에 있어서, R3이 수소이고 R4가 3급 알킬 또는 사이클로알킬이거나, R3과 R4가 이들이 결합되어 있는 질소원자와 함께 피페리디노 또는 헥사하이드로아제피노를 나타내는 화합물.
  6. 제1항에 있어서, N - 사이클로헥실-3-(1-(1,2,3,6-테트라하이드로-4-(5-메톡시-1H-인돌-3-일)피리딜))-2-페닐프로판아미톤 또는 2,3,4,5,6,7-헥사하이드로-1-(4-(1-(1,2,3,6-테트라하이드로-4-(2-메톡시페닐)피리딜))-2-페닐부티릴)-1H-아제핀 또는 (+)-2,3,4,5,6,7-헥사하이드로-1-(4(1-(1,2,3,6-테트라하이드로-4-(2-메톡시페닐)피리딜))-2-페닐부티닐)-1H-아제핀 또는 약제학적으로 허용되는 이들의 산 부가염인 화합물.
  7. (a) 일반식(II)의 화합물을 일반식(III)의 그룹을 제공하는 알킬화제로 알킬화시키거나, (b) 일반식(VII)의 아민을 일반시(VIII)의 산 또는 이의 아실화 유도체로 아실화시키거나, (c) 일반식(IX)의 하이드록시 아미드를 탈수시켜 ---이 이중결합을 나타내는 일반식(I)의 화합물을 수득하거나, (d) 제1항에 따른 화합물을 거울상 이성질체로 분할하거나, (e) 제1항에 따른 염기를 약제학적으로 허용되는 염으로 전환시키거나 약제학적으로 허용되는 염을 유리 염기로 전환시킴을 포함하여, 제1항에 따른 화합물을 제조하는 방법.
    상기식에서, a 및 b는 각각 0,1,2 또는 3이고, 단, a와 b의 합은 0,1,2 또는 3이며,은 a가 1이상인 경우, 환에 존재할 수 있는 임의의 이중결합이고, A는 하나 이상의 저급 알킬 그룹에 의해 임의로 치환된 탄소수 1 또는 2의 알킬렌 쇄이고, R은 모노 또는 비사이클릭 아릴 또는 헤테로아틸 라디칼이고, R1은 수소 또는 저급 알킬이고, R2는 아릴, 아릴(저급)알킬, 헤테로아릴 또는 헤테로아릴(저급)알킬 라디칼이고, R3은 수소 또는 저급 알킬이고, R4는 수소, 탄소수 1 내지 10의 알킬 그룹, 탄소수 3 내지 12의 사이클로알킬, 사이클로알킬(저급)알킬, 아릴 또는 아릴(저급)알킬이거나, R3과 R4는, 이들이 결합되어 있는 질소원자와 함께 추가의 헤테로 원자를 함유할 수 있는 포화 헤테로사이클릭 환율을 나타낸다.
  8. 제l항에 따른 화합물을 약제학적으로 허용되는 담체와 배합된 상태로 포함하는 약제학적 조성물.
  9. 제8항에 있어서, 화합물이 제7항의 방법으로 제조되는 약제학적 조성물.
  10. 제1항에 따른 화합물을 약제학적로 허용되는 담체와 배합함을 포함하여, 약제학적 조성물을 제조하는 방법.
  11. 제1항에 있어서, 5-HT1A길항제로서 사용하기 위한 화합물.
  12. 제1항에 있어서, 항우울제, 혈압강하제, 수면/비수면 주기 조절제, 급식 거동 조절제 또는 성기능 조절제 또는 불안치료제 또는 인식 장애 치료제로서 사용하기 위한 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950700456A 1992-08-05 1993-07-22 아미드 유도체(Amide derivatives) KR950702978A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB929216649A GB9216649D0 (en) 1992-08-05 1992-08-05 Amide derivatives
GB?9216649.5? 1992-08-05
GB?9307958.0? 1993-04-17
GB939307958A GB9307958D0 (en) 1993-04-17 1993-04-17 Amide derivateves
PCT/GB1993/001542 WO1994003444A1 (en) 1992-08-05 1993-07-22 Amide derivatives

Publications (1)

Publication Number Publication Date
KR950702978A true KR950702978A (ko) 1995-08-23

Family

ID=26301376

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950700456A KR950702978A (ko) 1992-08-05 1993-07-22 아미드 유도체(Amide derivatives)

Country Status (11)

Country Link
US (1) US5585374A (ko)
EP (1) EP0664801A1 (ko)
JP (1) JPH08501287A (ko)
KR (1) KR950702978A (ko)
AU (1) AU675964B2 (ko)
CA (1) CA2141810A1 (ko)
FI (1) FI950486A0 (ko)
HU (2) HUT71899A (ko)
PH (1) PH31209A (ko)
TW (1) TW288017B (ko)
WO (1) WO1994003444A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314758D0 (en) * 1993-07-16 1993-08-25 Wyeth John & Brother Ltd Heterocyclic derivatives
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
US5525600A (en) * 1994-11-28 1996-06-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
CA2334897A1 (en) 1998-06-30 2000-01-06 Eli Lilly And Company Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
EP0982304B1 (en) * 1998-06-30 2002-10-02 Eli Lilly And Company Piperidine derivatives having effects on serotonin related systems
CA2335310A1 (en) 1998-06-30 2000-01-06 Kenneth Lee Hauser Azepine derivatives having effects on serotonin related systems
AU2001281738B2 (en) 2000-07-21 2006-12-21 H.Lundbeck A/S Indole derivatives useful for the treatment of cns disorders
US6861427B2 (en) * 2001-04-26 2005-03-01 Wyeth Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
ITMI20021329A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilammine sostituite
US20040058962A1 (en) * 2002-06-14 2004-03-25 Amedeo Leonardi Phenylalkylamines and pyridylalkylamines

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3221019A (en) * 1964-04-07 1965-11-30 Aldrich Chem Co Inc N-alkinyl and n-alkinyloxy-amides of 4-phenyl - 1,2,5,6 - tetrahydropyridino alkanoic acids and intermediates thereof
US3221018A (en) * 1964-04-07 1965-11-30 Aldrich Chem Co Inc N-cyclopropyl amides of 4-phenyl-1,2,5,6-tetrahydropyridino alkanoic acids and intermediates thereof
NL173848C (nl) * 1970-06-01 1984-03-16 Janssen Pharmaceutica Nv Werkwijze ter bereiding van 2.2-diaryl 4-piperidino butyramiden; werkwijze ter bereiding van therapeutisch werkzame preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.
FR2533924A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
GB2208646B (en) * 1987-08-13 1991-06-26 Glaxo Group Ltd Indole derivatives
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
US5240942A (en) * 1990-07-10 1993-08-31 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
US5242933A (en) * 1990-07-10 1993-09-07 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
FR2664592B1 (fr) * 1990-07-10 1994-09-02 Adir Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
GB9022790D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
AU644488B2 (en) * 1990-10-19 1993-12-09 John Wyeth & Brother Limited Piperazine derivatives
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5525600A (en) * 1994-11-28 1996-06-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides

Also Published As

Publication number Publication date
FI950486A (fi) 1995-02-03
CA2141810A1 (en) 1994-02-17
AU4714593A (en) 1994-03-03
FI950486A0 (fi) 1995-02-03
US5585374A (en) 1996-12-17
HU211591A9 (en) 1995-12-28
TW288017B (ko) 1996-10-11
HUT71899A (en) 1996-02-28
PH31209A (en) 1998-05-05
HU9500330D0 (en) 1995-03-28
JPH08501287A (ja) 1996-02-13
WO1994003444A1 (en) 1994-02-17
AU675964B2 (en) 1997-02-27
EP0664801A1 (en) 1995-08-02

Similar Documents

Publication Publication Date Title
FI954105A0 (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
EA200300064A1 (ru) Карбоксамидные соединения и их применение в качестве антагонистов 11cby-рецептора человека
ES476305A1 (es) Un procedimiento para la preparacion de nuevos derivados aminicos
KR890003679A (ko) 시클릭 카르복실산 및 시클릭 알코올 및 아민의 에스테르와 아미드
NZ505586A (en) Indole and cyclopenta(b)pyrrole derivatives and pharmaceuticals thereof; useful as antagonists of the CCR2 (MCP-1) receptor
KR950702978A (ko) 아미드 유도체(Amide derivatives)
UA27818C2 (uk) Похідні індолу, які мають властивості агоністів 5-от1d рецепторів, спосіб їх одержання, фармацевтична композиція
ATE99295T1 (de) Benzimidazol-derivate mit pharmakologischer aktivitaet.
MY131762A (en) Pharmaceutical compounds
ATE196137T1 (de) Thiazolin-derivate
KR927003533A (ko) 피페라진 유도체
EP0397613A3 (en) Pharmacologically active aminoimidazopyridines
PE51499A1 (es) Derivados de 5-aroilnaftaleno
ES478691A1 (es) Procedimiento para la obtencion de un material organico de alto peso molecular aclarado opticamente.
ES2065668T3 (es) Piperidinas y pirrolidinas disubstituidas como agentes anticolinergicos.
AR037364A1 (es) Azetidinil diaminas utiles como ligandos del receptor de nociceptina orl-1
DE69319900T2 (de) N,n'-disubstituierte amidderivate
AR023528A1 (es) Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica
KR910007939A (ko) 헤테로사이클릭 화합물 및 이의 제조방법
CA2053705A1 (en) Piperazine derivatives
SE8303131D0 (sv) Isoquinoline derivatives
GB2014561A (en) Amine derivatives, their preparation and pharmaceutical compositions containing them
PE20001593A1 (es) Aralquilo mono-aciloxi utiles como relajantes musculares
DE69819315D1 (de) Verfahren zur herstellung von piperidincarbonsäureamiden

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid